We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Canadian firm Acerus Pharmaceuticals has signed a licence, development and supply agreement to grant Apsen Farmacêutica exclusive marketing rights for Natesto in Brazil.